These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 22374305)
1. Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium. Carbajo-Lozoya J; Lutz S; Feng Y; Kroll J; Hammes HP; Wieland T Cell Signal; 2012 Jun; 24(6):1261-9. PubMed ID: 22374305 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481 [TBL] [Abstract][Full Text] [Related]
3. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Fujita M; Hayashi I; Yamashina S; Fukamizu A; Itoman M; Majima M Carcinogenesis; 2005 Feb; 26(2):271-9. PubMed ID: 15637093 [TBL] [Abstract][Full Text] [Related]
4. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors. Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048 [TBL] [Abstract][Full Text] [Related]
5. Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF. Amaral SL; Linderman JR; Morse MM; Greene AS Microcirculation; 2001 Feb; 8(1):57-67. PubMed ID: 11296854 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin AT1 receptor upregulates expression of basic fibroblast growth factor, basic fibroblast growth factor receptor and coreceptor in human coronary smooth muscle cells. Skaletz-Rorowski A; Pinkernell K; Sindermann JR; Schriever C; Müller JG; Eschert H; Breithardt G Basic Res Cardiol; 2004 Jul; 99(4):272-8. PubMed ID: 15221345 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of in vivo angiogenesis by angiotensin II receptors. Walther T; Menrad A; Orzechowski HD; Siemeister G; Paul M; Schirner M FASEB J; 2003 Nov; 17(14):2061-7. PubMed ID: 14597675 [TBL] [Abstract][Full Text] [Related]
8. Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. Katada J; Muramatsu M; Hayashi I; Tsutsumi M; Konishi Y; Majima M J Pharmacol Exp Ther; 2002 Sep; 302(3):949-56. PubMed ID: 12183651 [TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. Ma X; Ottino P; Bazan HE; Bazan NG Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Haspel HC; Scicli GM; McMahon G; Scicli AG Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307 [TBL] [Abstract][Full Text] [Related]
11. Candesartan, an angiotensin II type 1 receptor antagonist, inhibits pathological retinal neovascularization by downregulating VEGF receptor-2 expression. Nakamura S; Tsuruma K; Shimazawa M; Hara H Eur J Pharmacol; 2012 Jun; 685(1-3):8-14. PubMed ID: 22543084 [TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity. Ohashi H; Takagi H; Oh H; Suzuma K; Suzuma I; Miyamoto N; Uemura A; Watanabe D; Murakami T; Sugaya T; Fukamizu A; Honda Y Circ Res; 2004 Apr; 94(6):785-93. PubMed ID: 14963002 [TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin II on human endothelial cells survival signalling pathways and its angiogenic response. Kou B; Vatish M; Singer DR Vascul Pharmacol; 2007 Oct; 47(4):199-208. PubMed ID: 17804301 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells. Fleegal-DeMotta MA; Doghu S; Banks WA J Cereb Blood Flow Metab; 2009 Mar; 29(3):640-7. PubMed ID: 19127280 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. Nagai N; Oike Y; Izumi-Nagai K; Urano T; Kubota Y; Noda K; Ozawa Y; Inoue M; Tsubota K; Suda T; Ishida S Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2252-9. PubMed ID: 16888236 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes. Otani A; Takagi H; Oh H; Suzuma K; Matsumura M; Ikeda E; Honda Y Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1192-9. PubMed ID: 10752960 [TBL] [Abstract][Full Text] [Related]
18. Adipocyte-derived leucine aminopeptidase suppresses angiogenesis in human endometrial carcinoma via renin-angiotensin system. Watanabe Y; Shibata K; Kikkawa F; Kajiyama H; Ino K; Hattori A; Tsujimoto M; Mizutani S Clin Cancer Res; 2003 Dec; 9(17):6497-503. PubMed ID: 14695154 [TBL] [Abstract][Full Text] [Related]
19. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085 [TBL] [Abstract][Full Text] [Related]